Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,023,000 | 6,687,000 | 5,552,000 | 3,709,000 | 5,319,000 |
| Marketable Securities | 839,000 | 2,535,000 | 2,567,000 | 1,366,000 | 2,815,000 |
| Receivables | 8,275,000 | 9,902,000 | 10,051,000 | 10,323,000 | 9,873,000 |
| Inventories | 6,093,000 | 7,267,000 | 6,744,000 | 5,930,000 | 6,093,000 |
| Other current assets | 9,331,000 | 4,151,000 | 3,090,000 | 2,756,000 | 2,585,000 |
| TOTAL | $37,561,000 | $30,542,000 | $28,004,000 | $24,084,000 | $26,685,000 |
| Non-Current Assets | |||||
| PPE Net | 15,983,000 | 18,197,000 | 16,939,000 | 15,627,000 | 15,840,000 |
| Investments And Advances | 10,152,000 | 10,748,000 | 9,957,000 | 9,560,000 | 10,225,000 |
| Intangibles | 53,143,000 | 58,867,000 | 61,421,000 | 61,912,000 | 64,923,000 |
| Other Non-Current Assets | 8,548,000 | 7,900,000 | 7,870,000 | 6,313,000 | 5,645,000 |
| TOTAL | $87,826,000 | $95,712,000 | $96,187,000 | $93,412,000 | $96,633,000 |
| Total Assets | $125,387,000 | $126,254,000 | $124,191,000 | $117,496,000 | $123,318,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,612,000 | 6,776,000 | 5,945,000 | 6,374,000 | 8,627,000 |
| Accounts payable and accrued liabilities | 5,419,000 | 6,148,000 | 5,593,000 | 4,989,000 | 4,788,000 |
| Other current liabilities | 10,448,000 | 10,935,000 | 10,443,000 | 10,079,000 | 9,533,000 |
| TOTAL | $26,973,000 | $26,368,000 | $24,051,000 | $23,148,000 | $24,658,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,799,000 | 11,242,000 | 13,781,000 | 13,855,000 | 14,360,000 |
| Other Non-Current Liabilities | 7,602,000 | 7,151,000 | 9,697,000 | 7,660,000 | 6,667,000 |
| TOTAL | $27,570,000 | $25,414,000 | $30,877,000 | $28,408,000 | $28,891,000 |
| Total Liabilities | $54,543,000 | $51,782,000 | $54,928,000 | $51,556,000 | $53,549,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,001,000 | 1,001,000 | 1,001,000 | 1,016,000 | 957,000 |
| Retained earnings | 69,868,000 | 73,431,000 | 68,228,000 | 64,949,000 | 62,364,000 |
| Other shareholders' equity | 78,000 | 129,000 | 126,000 | 96,000 | 6,573,000 |
| TOTAL | $70,844,000 | $74,472,000 | $69,263,000 | $65,940,000 | $69,769,000 |
| Total Liabilities And Equity | $125,387,000 | $126,254,000 | $124,191,000 | $117,496,000 | $123,318,000 |